{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:30:18Z","timestamp":1790688618090,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients undergoing haemodialysis (HD) are at higher risk of developing worse outcomes if they contract COVID-19. In our renal service we reduced HD frequency from thrice to twice-weekly in selected patients with the primary aim of reducing COVID 19 exposure and transmission between HD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Dialysis unit nephrologists identified 166 suitable patients (38.4% of our HD population) to temporarily convert to twice-weekly haemodialysis immediately prior to the peak of the COVID-19 pandemic in our area. Changes in pre-dialysis weight, systolic blood pressure (SBP) and biochemistry were recorded weekly throughout the 4-week project. Hyperkalaemic patients (serum potassium &gt;\u20096.0\u2009mmol\/L) were treated with a potassium binder, sodium bicarbonate and received responsive dietary advice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 12 deaths (5 due to COVID-19) in the HD population, 6 of which were in the twice weekly HD group; no deaths were definitively associated with change of dialysis protocol. A further 19 patients were either hospitalised and\/or developed COVID-19 and thus transferred back to thrice weekly dialysis as per protocol. 113 (68.1%) were still receiving twice-weekly HD by the end of the 4-week project. Indications for transfer back to thrice weekly were; fluid overload (19), persistent hyperkalaemia (4), patient request (4) and compliance (1). There were statistically significant increases in SBP and pre-dialysis potassium during the project.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Short term conversion of a large but selected HD population to twice-weekly dialysis sessions was possible and safe. This approach could help mitigate COVID-19 transmission amongst dialysis patients in centres with similar organisational pressures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-02172-2","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T08:07:49Z","timestamp":1607328469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safely reducing haemodialysis frequency during the COVID-19 pandemic"],"prefix":"10.1186","volume":"21","author":[{"given":"Michelle Da Silva","family":"Lodge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilini","family":"Abeygunaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Alderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Chrysochou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Donne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibi","family":"Erekosima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Hegarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lamerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nipah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"O\u2019Riordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Poulikakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rainone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharajan","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smeeta","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grahame","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9825-701X","authenticated-orcid":false,"given":"J.","family":"Tollitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"issue":"7","key":"2172_CR1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934.","journal-title":"JAMA Intern Med"},{"issue":"10229","key":"2172_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054.","journal-title":"Lancet."},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1492-7535.2004.01094.x","volume":"2","author":"BH Scribner","year":"2004","unstructured":"Scribner BH, Cole JJ, Ahmad S, Blagg CR. Why thrice weekly dialysis? Hemodial Int. 2004;2:188\u201392.","journal-title":"Hemodial Int"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41581-019-0226-4","volume":"16","author":"TA Ikizler","year":"2020","unstructured":"Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. Nat Rev Nephrol Nat Publ Group. 2020;16:1\u20133.","journal-title":"Nat Rev Nephrol Nat Publ Group"},{"key":"2172_CR5","first-page":"2020","volume":"37","author":"R Scarpioni","year":"2020","unstructured":"Scarpioni R, Manini A, Valsania T, De Amicis S, Albertazzi V, Melfa L, et al. Covid-19 and its impact on nephropathic patients: the experience at Ospedale \u201cGuglielmo da Saliceto\u201d in Piacenza. G Ital Nefrol. 2020;37:2020.","journal-title":"G Ital Nefrol"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.kint.2020.04.031","volume":"98","author":"M Goicoechea","year":"2020","unstructured":"Goicoechea M, S\u00e1nchez C\u00e1mara LA, Mac\u00edas N, Mu\u00f1oz de Morales A, Gonz\u00e1lez Rojas \u00c1, Bascu\u00f1ana A, et al. COVID-19: clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain. Kidney Int Elsevier. 2020;98:27.","journal-title":"Kidney Int Elsevier"},{"key":"2172_CR7","volume-title":"COVID-19 surveillance report for renal centres in the UK - up to 6th may 2020","author":"R Registry","year":"2020","unstructured":"Registry R. COVID-19 surveillance report for renal centres in the UK - up to 6th may 2020; 2020."},{"issue":"6","key":"2172_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1681\/ASN.2020030361","volume":"31","author":"TW Meyer","year":"2020","unstructured":"Meyer TW, Hostetter TH, Watnick S. Twice-weekly hemodialysis is an option for many patients in times of dialysis unit stress. J Am Soc Nephrol. 2020;31(6):1141.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2172_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1681\/ASN.2020040412","volume":"31","author":"R Mehrotra","year":"2020","unstructured":"Mehrotra R. Counterpoint: twice-weekly hemodialysis should be an approach of last resort even in times of dialysis unit stress. J Am Soc Nephrol. 2020;31(6):1143.","journal-title":"J Am Soc Nephrol"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ki.2015.141","volume":"88","author":"J Fotheringham","year":"2015","unstructured":"Fotheringham J, Fogarty DG, El Nahas M, Campbell MJ, Farrington K. The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. Kidney Int. 2015;88:569\u201375.","journal-title":"Kidney Int"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa1103313","volume":"365","author":"RN Foley","year":"2011","unstructured":"Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med. 2011;365:1099\u2013107.","journal-title":"N Engl J Med"},{"issue":"3","key":"2172_CR12","first-page":"222","volume":"372","author":"NICE","year":"2019","unstructured":"NICE. Sodium zirconium cyclosilicate for treating hyperkalaemia. Technol Apprais Guid[TA599]. NICE. 2019;372(3):222.","journal-title":"Technol Apprais Guid"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01542-9","volume":"18","author":"BiCARB study group","year":"2020","unstructured":"BiCARB study group. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial. BMC MedSpringer. 2020;18:1\u201316.","journal-title":"BMC Med"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1053\/j.ajkd.2011.02.376","volume":"57","author":"D Green","year":"2011","unstructured":"Green D, Roberts P, New D, Kalra P. Sudden cardiac death in hemodialysis patients: an in-depth review. Am J Kidney Dis. 2011;57:921\u20139.","journal-title":"Am J Kidney Dis"},{"key":"2172_CR15","first-page":"S64","volume":"16","author":"B Charra","year":"2003","unstructured":"Charra B, Chazot C, Jean G, Hurot JM, Vanel T, Terrat JC, et al. Long 3 x 8 hr dialysis: a three-decade summary. J Nephrol. 2003;16:S64\u20139.","journal-title":"J Nephrol"},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/hdi.12255","volume":"19","author":"P Kotanko","year":"2015","unstructured":"Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, et al. Effects of frequent hemodialysis on blood pressure: results from the randomized frequent hemodialysis network trials. Hemodial Int NIH Public Access. 2015;19:386\u2013401.","journal-title":"Hemodial Int NIH Public Access"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.0894-0959.2004.17324.x","volume":"17","author":"PJ Blankestijn","year":"2004","unstructured":"Blankestijn PJ, Ligtenberg G. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications. Semin Dial. 2004;17:265\u20139.","journal-title":"Semin Dial"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11906-011-0223-x","volume":"13","author":"TI Chang","year":"2011","unstructured":"Chang TI. Systolic blood pressure and mortality in patients on hemodialysis. Curr Hypertens Rep NIH Public Access. 2011;13:362\u20139.","journal-title":"Curr Hypertens Rep NIH Public Access"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000448341","volume":"44","author":"AA Yusuf","year":"2016","unstructured":"Yusuf AA, Hu Y, Singh B, Menoyo JA, Wetmore JB. Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study. Am J Nephrol S Karger AG. 2016;44:179\u201386.","journal-title":"Am J Nephrol S Karger AG"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000489961","volume":"47","author":"A Ferrey","year":"2018","unstructured":"Ferrey A, You AS, Kovesdy CP, Nakata T, Veliz M, Nguyen DV, et al. Dialysate potassium and mortality in a prospective hemodialysis cohort. Am J Nephrol NIH Public Access. 2018;47:415.","journal-title":"Am J Nephrol NIH Public Access"},{"issue":"2","key":"2172_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15586\/jrenhep.2018.34","volume":"2","author":"D Agrawal","year":"2018","unstructured":"Agrawal D, Agrawal D, Tripathi N, Segal M. Potassim profiling in hemodialysis. J Renal Hepatic Disord. 2018;2(2):6\u20139.","journal-title":"J Renal Hepatic Disord"},{"key":"2172_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12882-019-1527-3","volume":"20","author":"D Ashby","year":"2019","unstructured":"Ashby D, Borman N, Burton J, Corbett R, Davenport A, Farrington K, et al. Renal association clinical practice guideline on Haemodialysis. BMC Nephrol BioMed Central. 2019;20:379.","journal-title":"BMC Nephrol BioMed Central"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02172-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-02172-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02172-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T08:16:02Z","timestamp":1607328962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02172-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02172-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-41399\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-41399\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-41399\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-41399\/v3","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Online tools provided by the NHS Health Research Authority determined that research ethics committee review was not required in accordance with the UK Policy Framework for Health and Social Care Research. The study was performed in accordance with the declaration of Helsinki and approval for this study, including method of consent, was obtained from the Research and Innovation department of the Northern Care Alliance NHS Group (Ref: S19HRANA34). Patients provided verbal consent to be included in this project.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Professor Kalra reports grants and personal fees from Vifor, personal fees from AstraZeneca, outside the submitted work. No other authors have anything else to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}